Counteracting survival functions of EBNA3C in Epstein-Barr virus (EBV)-driven lymphoproliferative diseases by combination of SAHA and bortezomib
Kwai Fung Hui(Queen Mary Hospital), Aks Chiang(Hong Kong Adventist Hospital)
Cited by 8
Related Papers
Rituximab for High-Risk, Mature B-Cell Non-Hodgkin’s Lymphoma in Children
|New England Journal of Medicine|2020|308
Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir
|International Journal of Cancer|2015|93
Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism
|International Journal of Cancer|2014|68